SMTL ID : 7m8l.1

EBOV GP bound to rEBOV-442 and rEBOV-515 Fabs

Coordinates

PDB Format

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-3-3-3-3-3-mer

Ligands

6 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN.1: 4 residues within 4Å: Chain A: T.221, L.258, N.261, Y.265 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:Y.265 NAG-NAG-BMA-MAN-MAN.3: 9 residues within 4Å: Chain A: L.74, K.159, E.160, V.184 Chain D: Q.48, P.49, N.103, T.106 Chain P: F.75 1 PLIP interactions: 1 interactions with chain D Hydrophobic interactions: D:P.49 NAG-NAG-BMA-MAN-MAN.4: 4 residues within 4Å: Chain G: T.221, L.258, N.261, Y.265 1 PLIP interactions: 1 interactions with chain G Hydrophobic interactions: G:Y.265 NAG-NAG-BMA-MAN-MAN.6: 9 residues within 4Å: Chain D: F.75 Chain G: L.74, K.159, E.160, V.184 Chain J: Q.48, P.49, N.103, T.106 1 PLIP interactions: 1 interactions with chain J Hydrophobic interactions: J:P.49 NAG-NAG-BMA-MAN-MAN.7: 4 residues within 4Å: Chain M: T.221, L.258, N.261, Y.265 1 PLIP interactions: 1 interactions with chain M Hydrophobic interactions: M:Y.265 NAG-NAG-BMA-MAN-MAN.9: 9 residues within 4Å: Chain J: F.75 Chain M: L.74, K.159, E.160, V.184 Chain P: Q.48, P.49, N.103, T.106 1 PLIP interactions: 1 interactions with chain P Hydrophobic interactions: P:P.49

3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.2: 2 residues within 4Å: Chain A: N.232, E.233 No protein-ligand interaction detected (PLIP) NAG-NAG.5: 2 residues within 4Å: Chain G: N.232, E.233 No protein-ligand interaction detected (PLIP) NAG-NAG.8: 2 residues within 4Å: Chain M: N.232, E.233 No protein-ligand interaction detected (PLIP)

6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.10: 5 residues within 4Å: Chain A: N.272, T.273 Chain B: Y.118 Chain C: Y.50, S.54 2 PLIP interactions: 1 interactions with chain A, 1 interactions with chain B Hydrophobic interactions: A:T.273 Hydrogen bonds: B:Y.118 NAG.11: 2 residues within 4Å: Chain A: D.241, N.242 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:D.241 NAG.12: 5 residues within 4Å: Chain G: N.272, T.273 Chain H: Y.118 Chain I: Y.50, S.54 2 PLIP interactions: 1 interactions with chain G, 1 interactions with chain H Hydrophobic interactions: G:T.273 Hydrogen bonds: H:Y.118 NAG.13: 2 residues within 4Å: Chain G: D.241, N.242 1 PLIP interactions: 1 interactions with chain G Hydrogen bonds: G:D.241 NAG.14: 5 residues within 4Å: Chain M: N.272, T.273 Chain N: Y.118 Chain O: Y.50, S.54 2 PLIP interactions: 1 interactions with chain M, 1 interactions with chain N Hydrophobic interactions: M:T.273 Hydrogen bonds: N:Y.118 NAG.15: 2 residues within 4Å: Chain M: D.241, N.242 1 PLIP interactions: 1 interactions with chain M Hydrogen bonds: M:D.241

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gilchuk, P. et al., Pan-ebolavirus protective therapy by two multifunctional human antibodies. Cell (2021)

Release Date

2021-11-10

Peptides

Virion spike glycoprotein 1: AGM
rEBOV-442 Fab heavy chain: BHN
rEBOV-442 Fab light chain: CIO
Virion spike glycoprotein 2: DJP
rEBOV-515 Fab heavy chain: EKQ
rEBOV-515 Fab light chain: FLR

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

G
B

M
C

B
G

H
H

N
I

C
J

I
K

O
L

D
D

J
E

P
F

E
M

K
N

Q
O

F
P

L
Q

R
R

Virion spike glycoprotein 1

rEBOV-442 Fab heavy chain

rEBOV-442 Fab light chain

Virion spike glycoprotein 2

rEBOV-515 Fab heavy chain

rEBOV-515 Fab light chain

Related Entries With Identical Sequence